Target intelligence / Profile preview

Host and microbial cell-surface glycans and adhesion receptors

Molecular classification
Receptor, Enzyme, Glycan, Lectin, Cell adhesion molecule, Other
01

Overview

Host and microbial cell-surface glycans and adhesion receptors refers to the complex network of carbohydrate structures and their cognate binding proteins that mediate interactions at the cellular interface. Glycans, which are complex sugar chains attached to proteins and lipids, serve as essential recognition markers on the surfaces of all cells (Varki et al., Essentials of Glycobiology, 2017). Adhesion receptors, including lectins, selectins, and integrins, specifically recognize these glycan patterns to facilitate processes such as leukocyte trafficking, cell signaling, and tissue organization. In infectious diseases, pathogens exploit these host glycans as attachment sites for entry, while host immune cells use pattern recognition receptors to identify microbial-specific glycans (Imberty & Varrot, Curr Opin Struct Biol, 2008). Aberrant glycosylation and adhesion are also hallmarks of cancer metastasis and chronic inflammatory conditions. Consequently, this interface is a major focus for therapeutic development, with drugs like neuraminidase inhibitors and integrin blockers designed to disrupt pathological binding (Schnaar, Glycobiology of the Immune System, 2016).

Other names
Glycan-binding proteinsLectin-glycan interactionsCell surface carbohydratesMicrobial adhesinsHost-pathogen adhesion molecules
02

Mechanism of action

Inhibition of adhesion, competitive binding to glycans, enzymatic inhibition of glycan cleavage, blockade of receptor-ligand interaction

03

Biological functions

Cell-cell adhesionPathogen recognitionImmune responseSignal transductionCell-matrix interactionLeukocyte trafficking
04

Disease associations

InfectionInflammationCancerAutoimmune diseaseCardiovascular disease
05

Safety considerations

Impairment of normal immune surveillancePotential for systemic inflammatory responseOff-target binding to essential host glycansDisruption of the commensal microbiomeRisk of progressive multifocal leukoencephalopathy (PML)
06

Interacting drugs

Oseltamivir

6 more in the full profile.

07

Biomarkers

Sialyl-Lewis X (sLeX)Soluble Intercellular Adhesion Molecule-1 (sICAM-1)Cancer Antigen 19-9 (CA19-9)Cancer Antigen 125 (CA125)

Beyond the preview

Go deeper on Host and microbial cell-surface glycans and adhesion receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host and microbial cell-surface glycans and adhesion receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call